Nerve-Sparing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer
Background:Nerve-sparing techniques are used during retroperitoneal lymph node dissection (RPLND) in patients with early stage testicular cancer to preserve postoperative ejaculatory function. Indications for the procedures have been extended to patients with a postchemotherapy retroperitoneal resid...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Arai, Yoichi [verfasserIn] Ishitoya, Satoshi [verfasserIn] Okubo, Kazutoshi [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
Oxford, UK: Blackwell Publishing Ltd ; 1997 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
Online-Ressource |
|---|
| Reproduktion: |
2007 ; Blackwell Publishing Journal Backfiles 1879-2005 |
|---|---|
| Übergeordnetes Werk: |
In: International journal of urology - Oxford [u.a.] : Wiley-Blackwell, 1997, 4(1997), 5, Seite 0 |
| Übergeordnetes Werk: |
volume:4 ; year:1997 ; number:5 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1111/j.1442-2042.1997.tb00291.x |
|---|
| Katalog-ID: |
NLEJ242675859 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLEJ242675859 | ||
| 003 | DE-627 | ||
| 005 | 20210707162516.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 120427s1997 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1111/j.1442-2042.1997.tb00291.x |2 doi | |
| 035 | |a (DE-627)NLEJ242675859 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 100 | 1 | |a Arai, Yoichi |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Nerve-Sparing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer |
| 264 | 1 | |a Oxford, UK |b Blackwell Publishing Ltd |c 1997 | |
| 300 | |a Online-Ressource | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Background:Nerve-sparing techniques are used during retroperitoneal lymph node dissection (RPLND) in patients with early stage testicular cancer to preserve postoperative ejaculatory function. Indications for the procedures have been extended to patients with a postchemotherapy retroperitoneal residual mass without compromising the efficacy of surgery. We report 6 cases diagnosed with metastatic testicular cancer who underwent nerve-sparing RPLND. Methods:Between January 1994 and March 1996, 6 patients with metastatic testicular cancer underwent nerve-sparing RPLND. Five of these patients received primary chemotherapy and had a retroperitoneal residual mass. Four patients underwent complete bilateral RPLND and 2 underwent unilateral template surgery. Results:After a mean follow-up of 18.7 months (range, 8 to 34), there have been no local recurrences and 5 (83%) patients report antegrade ejaculation. Conclusion:Nerve-sparing RPLND is applicable for selected patients with metastatic testicular cancer without increasing the risk of local recurrence. Ejaculatory function is preserved in the majority of patients, contributing to the improvement of the quality of life in men who require such surgery. | ||
| 533 | |d 2007 |f Blackwell Publishing Journal Backfiles 1879-2005 |7 |2007|||||||||| | ||
| 650 | 4 | |a testicular cancer | |
| 700 | 1 | |a Ishitoya, Satoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Okubo, Kazutoshi |e verfasserin |4 aut | |
| 700 | 1 | |a Aoki, Yoshitaka |4 oth | |
| 700 | 1 | |a Okada, Takashi |4 oth | |
| 700 | 1 | |a Maeda, Hiroshi |4 oth | |
| 700 | 1 | |a Suzuki, Yuji |4 oth | |
| 773 | 0 | 8 | |i In |t International journal of urology |d Oxford [u.a.] : Wiley-Blackwell, 1997 |g 4(1997), 5, Seite 0 |h Online-Ressource |w (DE-627)NLEJ243925654 |w (DE-600)2009793-1 |x 1442-2042 |7 nnns |
| 773 | 1 | 8 | |g volume:4 |g year:1997 |g number:5 |g pages:0 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/j.1442-2042.1997.tb00291.x |q text/html |x Verlag |z Deutschlandweit zugänglich |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a ZDB-1-DJB | ||
| 912 | |a GBV_NL_ARTICLE | ||
| 951 | |a AR | ||
| 952 | |d 4 |j 1997 |e 5 |h 0 | ||
| author_variant |
y a ya s i si k o ko |
|---|---|
| matchkey_str |
article:14422042:1997----::evsaigerprtnalmhoeiscinomts |
| hierarchy_sort_str |
1997 |
| publishDate |
1997 |
| allfields |
10.1111/j.1442-2042.1997.tb00291.x doi (DE-627)NLEJ242675859 DE-627 ger DE-627 rakwb Arai, Yoichi verfasserin aut Nerve-Sparing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer Oxford, UK Blackwell Publishing Ltd 1997 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Background:Nerve-sparing techniques are used during retroperitoneal lymph node dissection (RPLND) in patients with early stage testicular cancer to preserve postoperative ejaculatory function. Indications for the procedures have been extended to patients with a postchemotherapy retroperitoneal residual mass without compromising the efficacy of surgery. We report 6 cases diagnosed with metastatic testicular cancer who underwent nerve-sparing RPLND. Methods:Between January 1994 and March 1996, 6 patients with metastatic testicular cancer underwent nerve-sparing RPLND. Five of these patients received primary chemotherapy and had a retroperitoneal residual mass. Four patients underwent complete bilateral RPLND and 2 underwent unilateral template surgery. Results:After a mean follow-up of 18.7 months (range, 8 to 34), there have been no local recurrences and 5 (83%) patients report antegrade ejaculation. Conclusion:Nerve-sparing RPLND is applicable for selected patients with metastatic testicular cancer without increasing the risk of local recurrence. Ejaculatory function is preserved in the majority of patients, contributing to the improvement of the quality of life in men who require such surgery. 2007 Blackwell Publishing Journal Backfiles 1879-2005 |2007|||||||||| testicular cancer Ishitoya, Satoshi verfasserin aut Okubo, Kazutoshi verfasserin aut Aoki, Yoshitaka oth Okada, Takashi oth Maeda, Hiroshi oth Suzuki, Yuji oth In International journal of urology Oxford [u.a.] : Wiley-Blackwell, 1997 4(1997), 5, Seite 0 Online-Ressource (DE-627)NLEJ243925654 (DE-600)2009793-1 1442-2042 nnns volume:4 year:1997 number:5 pages:0 http://dx.doi.org/10.1111/j.1442-2042.1997.tb00291.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 4 1997 5 0 |
| spelling |
10.1111/j.1442-2042.1997.tb00291.x doi (DE-627)NLEJ242675859 DE-627 ger DE-627 rakwb Arai, Yoichi verfasserin aut Nerve-Sparing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer Oxford, UK Blackwell Publishing Ltd 1997 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Background:Nerve-sparing techniques are used during retroperitoneal lymph node dissection (RPLND) in patients with early stage testicular cancer to preserve postoperative ejaculatory function. Indications for the procedures have been extended to patients with a postchemotherapy retroperitoneal residual mass without compromising the efficacy of surgery. We report 6 cases diagnosed with metastatic testicular cancer who underwent nerve-sparing RPLND. Methods:Between January 1994 and March 1996, 6 patients with metastatic testicular cancer underwent nerve-sparing RPLND. Five of these patients received primary chemotherapy and had a retroperitoneal residual mass. Four patients underwent complete bilateral RPLND and 2 underwent unilateral template surgery. Results:After a mean follow-up of 18.7 months (range, 8 to 34), there have been no local recurrences and 5 (83%) patients report antegrade ejaculation. Conclusion:Nerve-sparing RPLND is applicable for selected patients with metastatic testicular cancer without increasing the risk of local recurrence. Ejaculatory function is preserved in the majority of patients, contributing to the improvement of the quality of life in men who require such surgery. 2007 Blackwell Publishing Journal Backfiles 1879-2005 |2007|||||||||| testicular cancer Ishitoya, Satoshi verfasserin aut Okubo, Kazutoshi verfasserin aut Aoki, Yoshitaka oth Okada, Takashi oth Maeda, Hiroshi oth Suzuki, Yuji oth In International journal of urology Oxford [u.a.] : Wiley-Blackwell, 1997 4(1997), 5, Seite 0 Online-Ressource (DE-627)NLEJ243925654 (DE-600)2009793-1 1442-2042 nnns volume:4 year:1997 number:5 pages:0 http://dx.doi.org/10.1111/j.1442-2042.1997.tb00291.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 4 1997 5 0 |
| allfields_unstemmed |
10.1111/j.1442-2042.1997.tb00291.x doi (DE-627)NLEJ242675859 DE-627 ger DE-627 rakwb Arai, Yoichi verfasserin aut Nerve-Sparing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer Oxford, UK Blackwell Publishing Ltd 1997 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Background:Nerve-sparing techniques are used during retroperitoneal lymph node dissection (RPLND) in patients with early stage testicular cancer to preserve postoperative ejaculatory function. Indications for the procedures have been extended to patients with a postchemotherapy retroperitoneal residual mass without compromising the efficacy of surgery. We report 6 cases diagnosed with metastatic testicular cancer who underwent nerve-sparing RPLND. Methods:Between January 1994 and March 1996, 6 patients with metastatic testicular cancer underwent nerve-sparing RPLND. Five of these patients received primary chemotherapy and had a retroperitoneal residual mass. Four patients underwent complete bilateral RPLND and 2 underwent unilateral template surgery. Results:After a mean follow-up of 18.7 months (range, 8 to 34), there have been no local recurrences and 5 (83%) patients report antegrade ejaculation. Conclusion:Nerve-sparing RPLND is applicable for selected patients with metastatic testicular cancer without increasing the risk of local recurrence. Ejaculatory function is preserved in the majority of patients, contributing to the improvement of the quality of life in men who require such surgery. 2007 Blackwell Publishing Journal Backfiles 1879-2005 |2007|||||||||| testicular cancer Ishitoya, Satoshi verfasserin aut Okubo, Kazutoshi verfasserin aut Aoki, Yoshitaka oth Okada, Takashi oth Maeda, Hiroshi oth Suzuki, Yuji oth In International journal of urology Oxford [u.a.] : Wiley-Blackwell, 1997 4(1997), 5, Seite 0 Online-Ressource (DE-627)NLEJ243925654 (DE-600)2009793-1 1442-2042 nnns volume:4 year:1997 number:5 pages:0 http://dx.doi.org/10.1111/j.1442-2042.1997.tb00291.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 4 1997 5 0 |
| allfieldsGer |
10.1111/j.1442-2042.1997.tb00291.x doi (DE-627)NLEJ242675859 DE-627 ger DE-627 rakwb Arai, Yoichi verfasserin aut Nerve-Sparing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer Oxford, UK Blackwell Publishing Ltd 1997 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Background:Nerve-sparing techniques are used during retroperitoneal lymph node dissection (RPLND) in patients with early stage testicular cancer to preserve postoperative ejaculatory function. Indications for the procedures have been extended to patients with a postchemotherapy retroperitoneal residual mass without compromising the efficacy of surgery. We report 6 cases diagnosed with metastatic testicular cancer who underwent nerve-sparing RPLND. Methods:Between January 1994 and March 1996, 6 patients with metastatic testicular cancer underwent nerve-sparing RPLND. Five of these patients received primary chemotherapy and had a retroperitoneal residual mass. Four patients underwent complete bilateral RPLND and 2 underwent unilateral template surgery. Results:After a mean follow-up of 18.7 months (range, 8 to 34), there have been no local recurrences and 5 (83%) patients report antegrade ejaculation. Conclusion:Nerve-sparing RPLND is applicable for selected patients with metastatic testicular cancer without increasing the risk of local recurrence. Ejaculatory function is preserved in the majority of patients, contributing to the improvement of the quality of life in men who require such surgery. 2007 Blackwell Publishing Journal Backfiles 1879-2005 |2007|||||||||| testicular cancer Ishitoya, Satoshi verfasserin aut Okubo, Kazutoshi verfasserin aut Aoki, Yoshitaka oth Okada, Takashi oth Maeda, Hiroshi oth Suzuki, Yuji oth In International journal of urology Oxford [u.a.] : Wiley-Blackwell, 1997 4(1997), 5, Seite 0 Online-Ressource (DE-627)NLEJ243925654 (DE-600)2009793-1 1442-2042 nnns volume:4 year:1997 number:5 pages:0 http://dx.doi.org/10.1111/j.1442-2042.1997.tb00291.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 4 1997 5 0 |
| allfieldsSound |
10.1111/j.1442-2042.1997.tb00291.x doi (DE-627)NLEJ242675859 DE-627 ger DE-627 rakwb Arai, Yoichi verfasserin aut Nerve-Sparing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer Oxford, UK Blackwell Publishing Ltd 1997 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Background:Nerve-sparing techniques are used during retroperitoneal lymph node dissection (RPLND) in patients with early stage testicular cancer to preserve postoperative ejaculatory function. Indications for the procedures have been extended to patients with a postchemotherapy retroperitoneal residual mass without compromising the efficacy of surgery. We report 6 cases diagnosed with metastatic testicular cancer who underwent nerve-sparing RPLND. Methods:Between January 1994 and March 1996, 6 patients with metastatic testicular cancer underwent nerve-sparing RPLND. Five of these patients received primary chemotherapy and had a retroperitoneal residual mass. Four patients underwent complete bilateral RPLND and 2 underwent unilateral template surgery. Results:After a mean follow-up of 18.7 months (range, 8 to 34), there have been no local recurrences and 5 (83%) patients report antegrade ejaculation. Conclusion:Nerve-sparing RPLND is applicable for selected patients with metastatic testicular cancer without increasing the risk of local recurrence. Ejaculatory function is preserved in the majority of patients, contributing to the improvement of the quality of life in men who require such surgery. 2007 Blackwell Publishing Journal Backfiles 1879-2005 |2007|||||||||| testicular cancer Ishitoya, Satoshi verfasserin aut Okubo, Kazutoshi verfasserin aut Aoki, Yoshitaka oth Okada, Takashi oth Maeda, Hiroshi oth Suzuki, Yuji oth In International journal of urology Oxford [u.a.] : Wiley-Blackwell, 1997 4(1997), 5, Seite 0 Online-Ressource (DE-627)NLEJ243925654 (DE-600)2009793-1 1442-2042 nnns volume:4 year:1997 number:5 pages:0 http://dx.doi.org/10.1111/j.1442-2042.1997.tb00291.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 4 1997 5 0 |
| source |
In International journal of urology 4(1997), 5, Seite 0 volume:4 year:1997 number:5 pages:0 |
| sourceStr |
In International journal of urology 4(1997), 5, Seite 0 volume:4 year:1997 number:5 pages:0 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
testicular cancer |
| isfreeaccess_bool |
false |
| container_title |
International journal of urology |
| authorswithroles_txt_mv |
Arai, Yoichi @@aut@@ Ishitoya, Satoshi @@aut@@ Okubo, Kazutoshi @@aut@@ Aoki, Yoshitaka @@oth@@ Okada, Takashi @@oth@@ Maeda, Hiroshi @@oth@@ Suzuki, Yuji @@oth@@ |
| publishDateDaySort_date |
1997-01-01T00:00:00Z |
| hierarchy_top_id |
NLEJ243925654 |
| id |
NLEJ242675859 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ242675859</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210707162516.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120427s1997 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1111/j.1442-2042.1997.tb00291.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ242675859</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Arai, Yoichi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nerve-Sparing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford, UK</subfield><subfield code="b">Blackwell Publishing Ltd</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background:Nerve-sparing techniques are used during retroperitoneal lymph node dissection (RPLND) in patients with early stage testicular cancer to preserve postoperative ejaculatory function. Indications for the procedures have been extended to patients with a postchemotherapy retroperitoneal residual mass without compromising the efficacy of surgery. We report 6 cases diagnosed with metastatic testicular cancer who underwent nerve-sparing RPLND. Methods:Between January 1994 and March 1996, 6 patients with metastatic testicular cancer underwent nerve-sparing RPLND. Five of these patients received primary chemotherapy and had a retroperitoneal residual mass. Four patients underwent complete bilateral RPLND and 2 underwent unilateral template surgery. Results:After a mean follow-up of 18.7 months (range, 8 to 34), there have been no local recurrences and 5 (83%) patients report antegrade ejaculation. Conclusion:Nerve-sparing RPLND is applicable for selected patients with metastatic testicular cancer without increasing the risk of local recurrence. Ejaculatory function is preserved in the majority of patients, contributing to the improvement of the quality of life in men who require such surgery.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2007</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2007||||||||||</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">testicular cancer</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ishitoya, Satoshi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Okubo, Kazutoshi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aoki, Yoshitaka</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Okada, Takashi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maeda, Hiroshi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Suzuki, Yuji</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">International journal of urology</subfield><subfield code="d">Oxford [u.a.] : Wiley-Blackwell, 1997</subfield><subfield code="g">4(1997), 5, Seite 0</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ243925654</subfield><subfield code="w">(DE-600)2009793-1</subfield><subfield code="x">1442-2042</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:4</subfield><subfield code="g">year:1997</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1111/j.1442-2042.1997.tb00291.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">4</subfield><subfield code="j">1997</subfield><subfield code="e">5</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| series2 |
Blackwell Publishing Journal Backfiles 1879-2005 |
| author |
Arai, Yoichi |
| spellingShingle |
Arai, Yoichi misc testicular cancer Nerve-Sparing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer |
| authorStr |
Arai, Yoichi |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ243925654 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut |
| collection |
NL |
| publishPlace |
Oxford, UK |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1442-2042 |
| topic_title |
Nerve-Sparing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer testicular cancer |
| publisher |
Blackwell Publishing Ltd |
| publisherStr |
Blackwell Publishing Ltd |
| topic |
misc testicular cancer |
| topic_unstemmed |
misc testicular cancer |
| topic_browse |
misc testicular cancer |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
y a ya t o to h m hm y s ys |
| hierarchy_parent_title |
International journal of urology |
| hierarchy_parent_id |
NLEJ243925654 |
| hierarchy_top_title |
International journal of urology |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)NLEJ243925654 (DE-600)2009793-1 |
| title |
Nerve-Sparing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer |
| ctrlnum |
(DE-627)NLEJ242675859 |
| title_full |
Nerve-Sparing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer |
| author_sort |
Arai, Yoichi |
| journal |
International journal of urology |
| journalStr |
International journal of urology |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
1997 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Arai, Yoichi Ishitoya, Satoshi Okubo, Kazutoshi |
| container_volume |
4 |
| physical |
Online-Ressource |
| format_se |
Elektronische Aufsätze |
| author-letter |
Arai, Yoichi |
| doi_str_mv |
10.1111/j.1442-2042.1997.tb00291.x |
| author2-role |
verfasserin |
| title_sort |
nerve-sparing retroperitoneal lymph node dissection for metastatic testicular cancer |
| title_auth |
Nerve-Sparing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer |
| abstract |
Background:Nerve-sparing techniques are used during retroperitoneal lymph node dissection (RPLND) in patients with early stage testicular cancer to preserve postoperative ejaculatory function. Indications for the procedures have been extended to patients with a postchemotherapy retroperitoneal residual mass without compromising the efficacy of surgery. We report 6 cases diagnosed with metastatic testicular cancer who underwent nerve-sparing RPLND. Methods:Between January 1994 and March 1996, 6 patients with metastatic testicular cancer underwent nerve-sparing RPLND. Five of these patients received primary chemotherapy and had a retroperitoneal residual mass. Four patients underwent complete bilateral RPLND and 2 underwent unilateral template surgery. Results:After a mean follow-up of 18.7 months (range, 8 to 34), there have been no local recurrences and 5 (83%) patients report antegrade ejaculation. Conclusion:Nerve-sparing RPLND is applicable for selected patients with metastatic testicular cancer without increasing the risk of local recurrence. Ejaculatory function is preserved in the majority of patients, contributing to the improvement of the quality of life in men who require such surgery. |
| abstractGer |
Background:Nerve-sparing techniques are used during retroperitoneal lymph node dissection (RPLND) in patients with early stage testicular cancer to preserve postoperative ejaculatory function. Indications for the procedures have been extended to patients with a postchemotherapy retroperitoneal residual mass without compromising the efficacy of surgery. We report 6 cases diagnosed with metastatic testicular cancer who underwent nerve-sparing RPLND. Methods:Between January 1994 and March 1996, 6 patients with metastatic testicular cancer underwent nerve-sparing RPLND. Five of these patients received primary chemotherapy and had a retroperitoneal residual mass. Four patients underwent complete bilateral RPLND and 2 underwent unilateral template surgery. Results:After a mean follow-up of 18.7 months (range, 8 to 34), there have been no local recurrences and 5 (83%) patients report antegrade ejaculation. Conclusion:Nerve-sparing RPLND is applicable for selected patients with metastatic testicular cancer without increasing the risk of local recurrence. Ejaculatory function is preserved in the majority of patients, contributing to the improvement of the quality of life in men who require such surgery. |
| abstract_unstemmed |
Background:Nerve-sparing techniques are used during retroperitoneal lymph node dissection (RPLND) in patients with early stage testicular cancer to preserve postoperative ejaculatory function. Indications for the procedures have been extended to patients with a postchemotherapy retroperitoneal residual mass without compromising the efficacy of surgery. We report 6 cases diagnosed with metastatic testicular cancer who underwent nerve-sparing RPLND. Methods:Between January 1994 and March 1996, 6 patients with metastatic testicular cancer underwent nerve-sparing RPLND. Five of these patients received primary chemotherapy and had a retroperitoneal residual mass. Four patients underwent complete bilateral RPLND and 2 underwent unilateral template surgery. Results:After a mean follow-up of 18.7 months (range, 8 to 34), there have been no local recurrences and 5 (83%) patients report antegrade ejaculation. Conclusion:Nerve-sparing RPLND is applicable for selected patients with metastatic testicular cancer without increasing the risk of local recurrence. Ejaculatory function is preserved in the majority of patients, contributing to the improvement of the quality of life in men who require such surgery. |
| collection_details |
GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE |
| container_issue |
5 |
| title_short |
Nerve-Sparing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer |
| url |
http://dx.doi.org/10.1111/j.1442-2042.1997.tb00291.x |
| remote_bool |
true |
| author2 |
Ishitoya, Satoshi Okubo, Kazutoshi Aoki, Yoshitaka Okada, Takashi Maeda, Hiroshi Suzuki, Yuji |
| author2Str |
Ishitoya, Satoshi Okubo, Kazutoshi Aoki, Yoshitaka Okada, Takashi Maeda, Hiroshi Suzuki, Yuji |
| ppnlink |
NLEJ243925654 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth |
| doi_str |
10.1111/j.1442-2042.1997.tb00291.x |
| up_date |
2024-07-06T02:48:52.872Z |
| _version_ |
1803796226108293120 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ242675859</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210707162516.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120427s1997 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1111/j.1442-2042.1997.tb00291.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ242675859</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Arai, Yoichi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nerve-Sparing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford, UK</subfield><subfield code="b">Blackwell Publishing Ltd</subfield><subfield code="c">1997</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background:Nerve-sparing techniques are used during retroperitoneal lymph node dissection (RPLND) in patients with early stage testicular cancer to preserve postoperative ejaculatory function. Indications for the procedures have been extended to patients with a postchemotherapy retroperitoneal residual mass without compromising the efficacy of surgery. We report 6 cases diagnosed with metastatic testicular cancer who underwent nerve-sparing RPLND. Methods:Between January 1994 and March 1996, 6 patients with metastatic testicular cancer underwent nerve-sparing RPLND. Five of these patients received primary chemotherapy and had a retroperitoneal residual mass. Four patients underwent complete bilateral RPLND and 2 underwent unilateral template surgery. Results:After a mean follow-up of 18.7 months (range, 8 to 34), there have been no local recurrences and 5 (83%) patients report antegrade ejaculation. Conclusion:Nerve-sparing RPLND is applicable for selected patients with metastatic testicular cancer without increasing the risk of local recurrence. Ejaculatory function is preserved in the majority of patients, contributing to the improvement of the quality of life in men who require such surgery.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2007</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2007||||||||||</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">testicular cancer</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ishitoya, Satoshi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Okubo, Kazutoshi</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aoki, Yoshitaka</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Okada, Takashi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Maeda, Hiroshi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Suzuki, Yuji</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">International journal of urology</subfield><subfield code="d">Oxford [u.a.] : Wiley-Blackwell, 1997</subfield><subfield code="g">4(1997), 5, Seite 0</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ243925654</subfield><subfield code="w">(DE-600)2009793-1</subfield><subfield code="x">1442-2042</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:4</subfield><subfield code="g">year:1997</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1111/j.1442-2042.1997.tb00291.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">4</subfield><subfield code="j">1997</subfield><subfield code="e">5</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.398883 |